Literature DB >> 4974323

[A quantitative determination of factor 13 with anti-factor 13 serum].

H Bohn, H Haupt.   

Abstract

Mesh:

Substances:

Year:  1968        PMID: 4974323

Source DB:  PubMed          Journal:  Thromb Diath Haemorrh        ISSN: 0340-5338


× No keyword cloud information.
  13 in total

Review 1.  The human fibrin-stabilizing factors.

Authors:  H Bohn
Journal:  Mol Cell Biochem       Date:  1978-06-28       Impact factor: 3.396

2.  [Molecular structure of fibrin stabilizing factors in man. II. Comparative immunologic studies on factor XIII deficient plasma and normal plasma].

Authors:  H Bohn; W Becker; H Trobisch
Journal:  Blut       Date:  1973-05

3.  [Studies on plasma factor XIII-activity in acute leukaemia].

Authors:  H Rasche; M Dietrich; V Hiemeyer
Journal:  Klin Wochenschr       Date:  1972-11-01

4.  [Immunological studies on factor XIII and FSF-binding globulin].

Authors:  H Bohn
Journal:  Blut       Date:  1974-02

Review 5.  [Blood coagulation factor XIII and fibrin stabilization (author's transl)].

Authors:  H Rasche
Journal:  Klin Wochenschr       Date:  1975-12-15

6.  Factor XIII levels in relation to gynaecological operations.

Authors:  E Kidess; H Miller; A Preisner; R Briel
Journal:  Arch Gynecol       Date:  1979-08

7.  Significance of cross-linking of alpha 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis.

Authors:  Y Sakata; N Aoki
Journal:  J Clin Invest       Date:  1982-03       Impact factor: 14.808

8.  [Fibrinogen "Hannover", a further abnormal fibrinogen].

Authors:  M Barthels; G Sandvoss
Journal:  Blut       Date:  1977-02

9.  Congenital deficiency of alpha 2-plasmin inhibitor associated with severe hemorrhagic tendency.

Authors:  N Aoki; H Saito; T Kamiya; K Koie; Y Sakata; M Kobakura
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

10.  Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor.

Authors:  Y Sakata; N Aoki
Journal:  J Clin Invest       Date:  1980-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.